TMCITreace Medical Concepts, Inc.

$104M

Q4 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$69M+10.4% YoY

Gross Profit

$55M80.7% margin

Operating Income

-$204,000-0.3% margin

Net Income

-$501,000-0.7% margin

EPS (Diluted)

$-0.01

QoQ Revenue Growth

+52.4%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$7M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$217M

Total Liabilities

$104M

Stockholders' Equity

$113M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$69M	$62M	+10.4%
Gross Profit	$55M	$51M	+9.3%
Operating Income	-$204,000	-$7M	+97.0%
Net Income	-$501,000	-$6M	+92.0%

TMCI Q4 2024 Earnings — Treace Medical Concepts, Inc. Revenue & Financial Results | Market Cap Arena